Skip to main content
Steven Lin, MD, Radiation Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

StevenHseshengLinMDPhD

Radiation Oncology Houston, TX

Thoracic Cancer

Professor

Dr. Lin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lin's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Radiation Oncology, 2005 - 2009
  • Loma Linda University Health Education Consortium
    Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 2004 - 2005
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • CA State Medical License
    CA State Medical License 2006 - 2025
  • TX State Medical License
    TX State Medical License 2009 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2024
  • MS State Medical License
    MS State Medical License 2023 - 2024
  • AL State Medical License
    AL State Medical License 2023 - 2024
  • American Board of Radiology Radiation Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveill...  
    Hong Yang, Steven H Lin, Annals of Surgical Oncology
  • Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?☆  
    Zhongxing Liao, Saumil J Gandhi, Steven H Lin, ScienceDirect

Lectures

  • Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Dr. Lin on Combination Atezolizumab and Chemoradiation in Locally Advanced NSCLC
    Dr. Lin on Combination Atezolizumab and Chemoradiation in Locally Advanced NSCLCJune 10th, 2019
  • Multi-Institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes
    Multi-Institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and OutcomesJanuary 12th, 2018
  • Novel Radiation Therapy Techniques Should Become Standard in Esophageal Cancer Management
    Novel Radiation Therapy Techniques Should Become Standard in Esophageal Cancer ManagementApril 17th, 2017
  • Join now to see all

Hospital Affiliations